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Secretion of Pancreatic Polypeptide in Man in Response to Beef 
Ingestion is Mediated in Part by an Extravagal Cholinergic 
Mechanism 
B. Glaser, J.C. Floyd, Jr., and A.I. Vinik 
The effect of atropine, a muscarinic cholinergic blocking agent. on the response of plasma pancreatic polypeptide (hPP) to 
the ingestion of beef was investigated. Six healthy subjects ingested 250 g broiled ground beef on three occasions. After 
beef ingestion alone, the expected biphasic plasma hPP response was observed. On the two other occasions atropine 
(intravenous bolus followed by infusion) was begun either at 4 or 60 min after the beginning of beef ingestion so as to 
coincide with the early (first) and late (second) phases of hPP response to beef ingestion. On both occasions plasma hPP 
concentrations returned rapidly to baseline. Mean integrated incremental hPP responses in the absence of atropine were 
9.1 + 3.4 ng min ml-’ for the first phase (O-40 min) and 29.7 + 5.7 ng min ml-’ for the second phase (60-180 min); with 
atropine at 4 min. respective responses were 0.8 f 0.9 and - 1 .O f 1.3 ng min ml,-’ and with atropine at 60 min they were 
10.6 + 5.0 and 1.3 + 1.6 ng min ml.-’ After atropine administration, the half-time of disappearance of hPP from the 
circulation was 4-6 min. suggesting the complete cessation of stimulated hPP secretion. We conclude that the mechanisms 
of both the early and late phases of beef meal-stimulated release of hPP involve muscarinic cholinergic-neural transmission. 
The portion of the second (late) phase response which has been shown to persist after truncal vagotomy must be mediated 
by a cholinergic mechanism which is extravagal in character 
T HE INGESTION of a protein-rich meal causes biphasic release of human pancreatic polypeptide 
(hPP).‘,2*3 The initial phase of the response lasts 3&40 
min, and has cephalic,4S5 gastric’ and small-intestinal6 
components; within the first 6 mo after vagotomy, this 
initial phase is abolished.3*7 The second phase of hPP 
release occurs 30-40 min after meal ingestion, persists 
to some degree after vagotomy3,4v5*7 and appears, there- 
fore, to be vagally mediated only in part. Direct effects 
of absorbed nutrients upon the hPP cell to stimulate 
secretion of hPP are probably of minor consequence, 
since intravenously administered nutrients are at most 
only weak hPP secretagogues.‘*2*8*g,‘o Gut hormones 
released into blood and/or extravagal neural mecha- 
nisms in addition to vagal neural transmission may be 
important in the second phase of PP responses. 
Whereas others have investigated the effects of 
atropine when it was administered before food was 
ingested, we investigated its effect when administered 
after beef had been ingested and when early and late 
phase plasma hPP responses had already been ini- 
tiated. When atropine was given after the initiation of 
either phase, the plasma hPP concentration quickly 
returned to baseline, suggesting cholinergic mediation 
of both phases of hPP secretion stimulated by the 
ingestion of protein-rich meals. 
MATERIALS AND METHODS 
All subjects gave written consent to the study which had been 
approved by the Human Use Committee of the University of 
Michigan Hospital, Ann Arbor. 
Subjects 
Six subjects (21X32 yr-old) were within 15% of ideal body 
weight” and had normal glucose tolerance.” None had a family 
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history of diabetes or a history of cardiac disease. All had normal 
electrocardiograms. 
Tests 
Subjects fasted overnight and arrived at the Clinical Research 
Unit between 0730 and 0830 hr. All tests were done with the subjects 
seated in bed. A cannula was placed in an antecubital vein for blood 
sampling and kept patent with a dilute solution of heparin in saline 
(100 U/ml). A second cannula was placed in a vein in the opposite 
forearm for atropine infusion. Four basal samples were obtained at 
- 30, - 15, - 5, and 0 min. Care was taken so that the subjects could 
neither see nor smell the food before the last basal sample was 
obtained. The subjects were then instructed to consume one 50 g 
(uncooked weight) patty of broiled beef and one 30 ml glass of water 
every 2 min for 10 minutes. Salt and pepper were allowed ad libitum. 
Venous blood samples were taken in heparinized tubes, 3, 4, 5, 7, 8, 
10. 15,20,30,40, 50,55,60,65,70,80,90, 100. 120, 135, 150, 165, 
I80 min after the beginning of beef ingestion. 
Each subject ingested beef on three occasions in random order. On 
one occasion beef was ingested without atropine infusion. On 
another occasion, 15 fig/kg atropine was infused over 3 mitt, starting 
4 min after beginning the meal and was followed by an infusion of 17 
rg/kg/min which was maintained for 60 min. A third test was done 
using the same dose of atropine starting 60 min after beginning the 
meal. In some instances. when the atropine was given at 4 min. extra 
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water (30-60 ml) was needed to complete the meal. All subjects 
developed a dry mouth and sinus tachycardia during atropine 
infusion. 
Laboratory Methods 
Plasma was separated within 30 min by centrifugation and an 
aliquot taken for measurement of glucose. The remainder was stored 
at -20°C for hormone assay. For each hormone measured, all 
samples from an individual were assayed in a single assay. 
Pancreatic Polypeptide Assay 
The plasma hPP concentrations were measured by a radioimmu- 
noassay (RIA);” rabbit anti-hPP serum (Lot 615-1054B-248-18*), 
hPP (Lot 615.1054B-200*) as reference standard, and ‘? labeled 
bovine PP (bPP) (Lot 615-D63-188-9’) tracer was used. The mean 
least-detection limit of the assays was 49 pg/ml plasma. The 
intraassay coelhcient of variation was 12%. 
Insulin Assay 
Immunoreactive insulin (IRI) was measured by a double antibody 
RIA.” The least detection limit was 1.5 &l/ml plasma. The 
intraassay variation was 5.0%. 
Glucagon Assay 
Plasma levels of “pancreatic” glucagon (IRG) were measured 
using a double antibody RIA (15). The antiserum, G9-1 (Ann 
Arbor, MI) used in the assay detects the C-terminal region of the 
glucagon molecule and has negligible (2%5%) cross reactivity with 
intestinal glucagon-like material (GLI). It does, however, detect 
glucagon of varying molecular weight. The least detection limit was 
34 pg/ml plasma, the intraassay variation was 4.1%. 
Plasma glucose was measured by the procedure of Worthington 
Biochemical Company based on the coupled-enzyme method of 
Slein,16 using hexokinase and glucose-6-phosphate dehydrogenase, 
with modifications by Bondar and Mead.17 
Statistical Methods 
The results are presented as means + SE and are given both as 
hPP concentrations (pg/ml) at time points indicated and as incre- 
mental response areas above basal (ng min ml-‘) for each of the two 
phases. Phase I (early phase of beef meal-induced hPP release) was 
defined as the period from 0 to 40 min. Phase II (late phase) was 
defined as 6&l 80 min; this definition made it possible to compare 
control and atropine test results for only that portion of phase II that 
followed the time (60 min) at which atropine began to be adminis- 
tered. For the six control tests the nadir between phases I and II 
occurred at 32 + 4 min (mean * SE). Significant differences in 
plasma hPP incremental area responses of the pairings of the three 
experimental conditions were determined using the paired t test. A p 
value of to.05 was considered significant. The half-time (t ‘/2) of 
disappearance of hPP from plasma was calculated by linear regres- 
sion of log hPP concentration vs. time, where t 5 = 0.693/Ke. Ke is 
the slope of disappearance of hPP from the circulation. Time points 
7, 8, 10, 15, and 60, 65, 70 min respectively were used for the 
calculation of the half-time of disappearance when atropine had 
been administered at 4 and 60 min. 
*Kindly donated by R. Chance, Eli Lilly and Company, Indianap- 
olis, Indiana. 
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RESULTS 
Ingestion of Beef Control Test 
The biphasic plasma hPP response to beef ingestion 
is shown in Fig. 1A. The mean + SE of the basal 
plasma hPP concentrations was 98 + 8 pg/ml. The 
mean t SE of maximal hPP concentrations was 499 t 
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Fig. 1. Plasma hPP response of 6 healthy subjects to ingestion 
of 260 g beef plus 160 ml water over 10 min: (a) without atropine, 
(bl with infusion of atropine begun at 4 min and (c) atropine begun 
at 60 min. See Materials and Methods for details of atropine 
administration. The shaded area in panels B and C encompasses 
the mean t SE of the plasma concentration during the control test 
(panel A). 
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Table 1. Incremental Plasma hPP Response Areas 
to Beef Ingestion 
Phase I Phase II 
IO fo 40 min.) (60 to 180 min.) 
(ng.min.ml~’ t SE) 
Control 9.1 t 3.4 
Atropine at 4 min 0.8 + 0.9* 
Atropine at 60 min 10.6 ” 5.0 
‘p < 0.05 Compared to Control. 
29.7 f 5.7 
-1.1 t 1.3’ 
1.3 + 1.6’ 
occurred 16.7 f 2.8 min after beginning the meal 
ingestion. Plasma hPP levels fell to a mean nadir at 30 
min, after which a second rise began and reached a 
mean maximal concentration of 465 * 57 pg/ml (not 
shown in figure), at 144 f 17 min. The incremental 
area (mean + SE) of plasma hPP response for the first 
phase ((r40 min) was 9.1 + 3.4 ng min ml-’ and for 
the second phase (60-180 min) was 29.7 + 5.7 ng min 
ml-’ (Table 1). incremental area responses of glucose, 
insulin (IRI), and glucagon (IRG) are shown in Table 
2. IRI rose significantly above basal during phase I 
(289 k 112 rIJ min ml-‘) and phase II (1718 * 407) 
of the test (Table 2). 
(Tables 1 and 2) were similar to those during the 
control test. Following the phase I peak, hPP concen- 
trations decreased to a mean nadir of 281 + 45 pg/ml 
at 41 + 4 min which was similar to the control response 
(Fig. 1 C). The mean plasma hPP then rose to 345 + 35 
pg/ml at 60 min at which time atropine administration 
was begun. Within 5 min mean plasma hPP concentra- 
tion had begun to fall and had returned to the basal 
level by 90 min. Thus, for phase II the incremental 
integrated hPP response area, 1.3 + 1.6 ng min ml,-’ 
was significantly less than the response during the 
control test (Table 1). Phase II IRI, IRG, and glucose 
responses were also less than those during the control 
test. 
In all subjects, the administration of atropine 
resulted in a rapid fall of hPP concentrations to basal 
levels. The mean half-time of disappearance of hPP 
from plasma was 4.17 min when atropine was given at 
4 min, and 5.88 min when it was given at 60 min. 
DISCUSSION 
Ingestion of Beef Atropine Administered at 4 Min 
During this test (Fig. 1 B) mean hPP concentration 
rose rapidly from a basal of 105 f 13 pg/ml to 198 + 
54 pg/ml at 4 min when atropine was begun. Mean 
plasma hPP concentration continued to rise for 
another 1 min after which it fell to reach baseline at 15 
min where it remained for the duration of the test. The 
mean maximal hPP concentration during phase I was 
237 t 58 pg/ml reached at 5.7 min. The incremental 
response areas for phase I, 0.8 f 0.9 ng min ml,-’ and 
for phase II, - 1.1 + 1.3 ng min ml,-’ were signifi- 
cantly less (p -c 0.05) than the control responses (Ta- 
ble 1). The insulin response was abolished in both 
phase I and phase II (Table 2). In both phases gluca- 
gon and glucose increased less than during the control 
test. 
These studies demonstrate that both the early 
(phase I) and late (phase II) phases of the plasma hPP 
response to protein ingestion are rapidly terminated by 
atropine infusion and, therefore, are cholinergically 
mediated. Taylor et al. had shown in the dog that 
administration of cholinergic blocking agents prior to 
meal ingestion prevents development of both phases.’ 
In the present study we administered atropine in 
separate experiments soon after the early and soon 
after the late phases had been established. In this way 
the observed effects of cholinergic blockade could be 
related more particularly to mechanisms which con- 
tribute to these two response phases. 
The early phase of hPP release by food ingestion 
appears to be mediated by the vagus nerve as it is 
eliminated by truncal vagotomy.‘.‘.‘.’ It was, therefore, 
not unexpected that an early phase response already 
initiated would be abolished by atropine administra- 
tion. 
Ingestion of BeeJ Atropine Administered at 60 Min 
Phase I plasma hPP concentrations (Fig. 1C) and 
plasma hPP, IRI, IRG and glucose response areas 
The mechanisms mediating the second phase of the 
plasma hPP response which becomes discernable at 
3&40 min after protein ingestion appear to be more 
Table 2. Incremental Plasma Insulin, Glucagon and Glucose Response Areas to Beef Ingestion 
Phase I Phase II 
(O-40 mm.1 (60-180 men.) 
lnsulnl Glucagon GlWO$e Insulin Glucagon 
pU.mm.ml~’ pg.min.mle’ mg.mm.dlK’ gU.min.ml-’ pg.min.mlY’ 
Control t289 -+ 112 514 f 336 56 + 25 tl.718 + 407 3,891 + 1,746 
Atropine at 4 min 23 k 69’ -22 + a7 -100 + 90 53 k 237* - 1,026 + 704’ 
Atropine at 60 mtn t304 + 145 391 k 64 -17 + 54 t546 + 216’ 1,041 r 395 
l Signifcant decrease from control area p < 0.05. 
tSigniflcant response above basal area p < 0.05. 
GlUCOS‘Z 
mg.mm.dl~’ 
385 -c 326 
- 136 + 295. 
-234 2 257’ 
60 
complex than those which mediate phase I response. 
The stimulus for phase II release probably includes 
stretching of the stomach’* and duodenum6 and the 
effects of particular nutrients in the stomach and 
i*te~tine.'.'0.19.20 The degree to which the signals for 
phase II meal-induced release of hPP originate in the 
stomach as compared to the intestine is unknown, but 
the persistence of the plasma hPP response for up to 6 
hr after the ingestion of protein’ suggests a major role 
for the intestine. Circulating absorbed products of 
digestion evidently contribute little or none’~2~9~‘0~2’ to 
the phase II response. It can be presumed that the 
intestinal component of the phase II response was 
present at the time of late (60 min) atropine adminis- 
tration since a significant degree of gastric emptying 
would have occurred by that time. Some phase II 
response is demonstrable consistently early (~6 mo) 
and late after truncal vagotomy and pyloroplasty in 
man3.5.9 and dog;’ vagal denervation was confirmed by 
the Hollander test’ and pentagastrin stimulation.3 The 
persistence of a phase II response in the absence of 
vagal inervation indicates the participation in the 
response of an extravagal mechanism. The abrupt 
complete termination of the response by atropine as 
shown in this study indicates that the phase II extrava- 
gal mechanism is cholinergic in nature. 
GLASER, FLOYD, AND VINIK 
This extravagal mechanism may be humoral, neural 
or both.5 One or more GI hormones released into blood 
in response to a meal may contribute as a humoral 
extravagal mechanism(s) for hPP release. Secretin22’23 
CCK-822 and bombesin,24 each stimulates the release 
of hPP, but this has not been demonstrated at physio- 
logic doses. As is the case of phase II beef response, the 
stimulating effect of secretin is demonstrable after 
truncal vagotomy but is entirely blocked by atropine.23 
Neural extravagal signal transmission requires postu- 
lation of nerves directly connecting the gastrointestinal 
tract and the pancreatic endocrine cells, as well as a 
means by which particular nutrients in the gastrointes- 
tinal tract activate this transmission system. 
The increases in IRI and IRG plasma levels were 
relatively small and response phases not as distinct as 
with hPP. The effects of atropine upon the IRI and 
IRG response areas during phases I and II, however, 
were qualitatively similar to the effects upon the hPP 
response areas and, therefore, may have been mediated 
through a similar mechanism(s). Knowledge of the 
character and route of signals transmitted from the GI 
tract to the hPP cell may have a more general applica- 
bility, i.e., to the regulation of secretion of other 
pancreatic endocrine cells. 
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